MA40446A - Procédé de préparation de formulations pour inhalation - Google Patents

Procédé de préparation de formulations pour inhalation

Info

Publication number
MA40446A
MA40446A MA040446A MA40446A MA40446A MA 40446 A MA40446 A MA 40446A MA 040446 A MA040446 A MA 040446A MA 40446 A MA40446 A MA 40446A MA 40446 A MA40446 A MA 40446A
Authority
MA
Morocco
Prior art keywords
inhalation
preparing formulations
formulations
preparing
Prior art date
Application number
MA040446A
Other languages
English (en)
Inventor
Özlem Akdas
Devrim Celik
Ali Türkyilmaz
Original Assignee
Arven Ilac Sanayi Ve Ticaret As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arven Ilac Sanayi Ve Ticaret As filed Critical Arven Ilac Sanayi Ve Ticaret As
Publication of MA40446A publication Critical patent/MA40446A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA040446A 2014-07-09 2015-07-08 Procédé de préparation de formulations pour inhalation MA40446A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR201408049 2014-07-09

Publications (1)

Publication Number Publication Date
MA40446A true MA40446A (fr) 2018-03-07

Family

ID=52003034

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040446A MA40446A (fr) 2014-07-09 2015-07-08 Procédé de préparation de formulations pour inhalation

Country Status (10)

Country Link
US (1) US20170266135A1 (fr)
EP (1) EP3166594B1 (fr)
EA (1) EA031373B1 (fr)
ES (1) ES2672383T3 (fr)
GE (2) GEAP201814415A (fr)
MA (1) MA40446A (fr)
PL (1) PL3166594T3 (fr)
PT (1) PT3166594T (fr)
TR (1) TR201807647T4 (fr)
WO (1) WO2016005447A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201903872SA (en) 2016-10-31 2019-05-30 Thales Australia Ltd Acoustic transducer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6006174A (en) * 1990-10-03 1999-12-21 Interdigital Technology Coporation Multiple impulse excitation speech encoder and decoder
RU2312854C2 (ru) 2001-09-14 2007-12-20 Глаксо Груп Лимитед Производные фенэтаноламина для лечения респираторных заболеваний
CA2661481A1 (fr) * 2006-08-22 2008-02-28 Boehringer Ingelheim International Gmbh Formulations de poudre pour inhalation contenant des beta-agonistes purs sur le plan enantiomerique
US7982521B2 (en) * 2006-10-03 2011-07-19 Freescale Semiconductor, Inc. Device and system for reducing noise induced errors
PL3578169T3 (pl) * 2009-02-26 2024-09-02 Glaxo Group Limited Preparaty farmaceutyczne zawierające 4-{(1r)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol
AU2011298315B2 (en) * 2010-08-31 2014-08-28 Glaxo Group Limited Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same

Also Published As

Publication number Publication date
PL3166594T3 (pl) 2018-09-28
EA201692453A1 (ru) 2017-04-28
ES2672383T3 (es) 2018-06-14
EP3166594B1 (fr) 2018-03-07
GEP20196944B (en) 2019-02-11
WO2016005447A1 (fr) 2016-01-14
GEAP201814415A (en) 2018-10-25
EP3166594A1 (fr) 2017-05-17
EA031373B1 (ru) 2018-12-28
TR201807647T4 (tr) 2018-06-21
PT3166594T (pt) 2018-06-06
US20170266135A1 (en) 2017-09-21

Similar Documents

Publication Publication Date Title
EP3398960A4 (fr) Procédé de préparation du sermaglutide
MA52906A (fr) Procédé de préparation d'amg 416
MA54253A (fr) Procédé de préparation de dérivés de 2-chloro-4-hétéroaryl-pyridimidines
ZA201708142B (en) Process for preparing 4-amino-pyridazines
IL252912A0 (en) Processes for preparing oxathiazine-like compounds
HUE050974T2 (hu) Eljárás pirimidinszulfamid-származékok elõállítására
ZA201706795B (en) Process for the preparation of dicycloplatin
EP3341359A4 (fr) Procédé de préparation d'aprémilast
IL248267B (en) A process for preparing converted cycloserines
IL253877A0 (en) Process for preparing 3-chloro-2-vinylphenylsulfonates
EP3350154A4 (fr) Procédé amélioré de préparation de dichlorhydrate de trientine
EP3265100A4 (fr) Procédés de préparation de fluorokétolides
EP3444253A4 (fr) Procédé de préparation de ad-35
EP3455210A4 (fr) Procédé de préparation de boscalide
IL247443B (en) Process for the preparation of 5-fluorotryptophol
EP3307717A4 (fr) Nouveau procédé de préparation d'enzalutamide
MA42264A (fr) Procédé de préparation d'oltipraz
GB2522454B (en) Positioning system for implement of machine
FR3024729B1 (fr) Procede de preparation du trioxane
IL249283A0 (en) Process for the preparation of 3-chloro-2-vinylphenol
EP3119573C0 (fr) Procédé de préparation de béton
EP3312174A4 (fr) Procédé de préparation de trityl candésartan
PL3223799T3 (pl) Sposób otrzymywania kompozycji składnik farmaceutyczny-polimer
MA40446A (fr) Procédé de préparation de formulations pour inhalation
EP3310755A4 (fr) Nouveau procédé de préparation de tériflunomide